rs56379561

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_052989.3(IFT122):​c.740+15G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 1,610,426 control chromosomes in the GnomAD database, including 12,066 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1709 hom., cov: 33)
Exomes 𝑓: 0.11 ( 10357 hom. )

Consequence

IFT122
NM_052989.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.274

Publications

5 publications found
Variant links:
Genes affected
IFT122 (HGNC:13556): (intraflagellar transport 122) This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This cytoplasmic protein contains seven WD repeats and an AF-2 domain which function by recruiting coregulatory molecules and in transcriptional activation. Mutations in this gene cause cranioectodermal dysplasia-1. A related pseudogene is located on chromosome 3. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
IFT122 Gene-Disease associations (from GenCC):
  • cranioectodermal dysplasia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
  • cranioectodermal dysplasia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 3-129467081-G-A is Benign according to our data. Variant chr3-129467081-G-A is described in ClinVar as Benign. ClinVar VariationId is 262273.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.229 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IFT122NM_052989.3 linkc.740+15G>A intron_variant Intron 8 of 29 ENST00000348417.7 NP_443715.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IFT122ENST00000348417.7 linkc.740+15G>A intron_variant Intron 8 of 29 1 NM_052989.3 ENSP00000324005.4

Frequencies

GnomAD3 genomes
AF:
0.132
AC:
20157
AN:
152144
Hom.:
1703
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.220
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.106
Gnomad ASJ
AF:
0.166
Gnomad EAS
AF:
0.0817
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.0390
Gnomad MID
AF:
0.101
Gnomad NFE
AF:
0.0942
Gnomad OTH
AF:
0.143
GnomAD2 exomes
AF:
0.117
AC:
29110
AN:
249336
AF XY:
0.124
show subpopulations
Gnomad AFR exome
AF:
0.223
Gnomad AMR exome
AF:
0.0708
Gnomad ASJ exome
AF:
0.167
Gnomad EAS exome
AF:
0.0769
Gnomad FIN exome
AF:
0.0387
Gnomad NFE exome
AF:
0.0955
Gnomad OTH exome
AF:
0.122
GnomAD4 exome
AF:
0.108
AC:
157776
AN:
1458164
Hom.:
10357
Cov.:
32
AF XY:
0.113
AC XY:
81840
AN XY:
725496
show subpopulations
African (AFR)
AF:
0.230
AC:
7691
AN:
33388
American (AMR)
AF:
0.0739
AC:
3301
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.168
AC:
4376
AN:
26116
East Asian (EAS)
AF:
0.0644
AC:
2555
AN:
39680
South Asian (SAS)
AF:
0.248
AC:
21391
AN:
86140
European-Finnish (FIN)
AF:
0.0409
AC:
2166
AN:
52910
Middle Eastern (MID)
AF:
0.164
AC:
827
AN:
5040
European-Non Finnish (NFE)
AF:
0.0974
AC:
108133
AN:
1109998
Other (OTH)
AF:
0.122
AC:
7336
AN:
60216
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
6220
12441
18661
24882
31102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4210
8420
12630
16840
21050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.133
AC:
20183
AN:
152262
Hom.:
1709
Cov.:
33
AF XY:
0.132
AC XY:
9835
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.220
AC:
9145
AN:
41510
American (AMR)
AF:
0.106
AC:
1627
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.166
AC:
576
AN:
3468
East Asian (EAS)
AF:
0.0811
AC:
421
AN:
5188
South Asian (SAS)
AF:
0.240
AC:
1159
AN:
4824
European-Finnish (FIN)
AF:
0.0390
AC:
414
AN:
10620
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0942
AC:
6410
AN:
68028
Other (OTH)
AF:
0.144
AC:
305
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
857
1715
2572
3430
4287
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
216
432
648
864
1080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.123
Hom.:
300
Bravo
AF:
0.139
Asia WGS
AF:
0.204
AC:
714
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 13, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Cranioectodermal dysplasia 1 Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cranioectodermal dysplasia Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
3.2
DANN
Benign
0.61
PhyloP100
0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56379561; hg19: chr3-129185924; COSMIC: COSV56203848; COSMIC: COSV56203848; API